Updated Jul 16, 2026
Wu Xiaobin has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $28.63M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-25 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 1.3K | $276.26 | $357K |
| 2026-06-18 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 1.4K | $266.76 | $362K |
| 2026-06-15 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 626 | $261.20 | $164K |
| 2026-06-15 | ONC | BeOne Medicines Ltd. | A — Grant or award | 118.6K | $0.00 | |
| 2026-06-10 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 40 | $270.55 | $11K |
| 2026-06-10 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 1.4K | $269.33 | $389K |
| 2026-03-11 | ONC | BeOne Medicines Ltd. | A — Grant or award | 78.6K | $0.00 | |
| 2026-03-11 | ONC | BeOne Medicines Ltd. | A — Grant or award | 168.9K | $0.00 | |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 600 | $308.03 | $185K |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 4.9K | $307.43 | $1.51M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 12.2K | $306.26 | $3.75M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 8.5K | $305.48 | $2.60M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 500 | $304.19 | $152K |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 7.0K | $303.31 | $2.11M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 5.8K | $302.04 | $1.75M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 400 | $300.86 | $120K |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | M — Option exercise | 9.2K | $159.03 | $1.46M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | M — Option exercise | 30.8K | $155.68 | $4.79M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 9.6K | $307.38 | $2.96M |
| 2025-08-13 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 9.6K | $306.74 | $2.96M |
Wu Xiaobin is a corporate insider — currently tracked as President and COO of BeOne Medicines Ltd. (ONC). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 22 open-market sales ($28.63M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wu Xiaobin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.